Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: According to Barco,the 336 has problems,they put their money wheretheir mouth is

<if TPL substantively amended claims 6 and 10 during the reexamination of the ’336 patent, TPL is only entitled to recover damages for alleged infringement occurring after the completion of the reexamination.>

Even if the the above is the case, wouldn't they still be infringing on claim #1 from day #1 of the infringement notification. Claim #1 does not contain the external/off-chip amendment which is being argued above, and does contain the essence of the invention.

Is it necessary to infringe on more than one claim?

Opty

Share
New Message
Please login to post a reply